Qube Research & Technologies Ltd - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$491,165
-89.5%
2,265
-89.1%
0.00%
-92.9%
Q3 2022$4,680,000
+705.5%
20,808
+308.4%
0.03%
+300.0%
Q2 2021$581,0005,0950.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders